Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Provides historical benchmark for CSDH in elderly; leaves open whether incidence and antithrombotic risks have evolved in contemporary cohorts.
Asghar et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: